Resolving the intoxication mechanism of botulinum neurotoxins using single molecule structural biology
利用单分子结构生物学解析肉毒杆菌神经毒素的中毒机制
基本信息
- 批准号:10717466
- 负责人:
- 金额:$ 42.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-20 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:BiophysicsBotulinum ToxinsC-terminalCellular MembraneCholera ToxinClassificationClinicalClinical TrialsClostridium botulinumCosmeticsCrystallizationDataDevelopmentDiphtheria ToxinDrug KineticsElectron MicroscopyElectrophysiology (science)EndosomesEnzymesEvolutionFamilyFluorescenceFluorescence Resonance Energy TransferGoalsHeterogeneityImaging technologyIndividualIntoxicationInvestigationIon ChannelKnowledgeLeftLifeLightLinkLiposomesMarketingMembraneMembrane LipidsMethodsModelingMolecularMolecular ConformationN-terminalNeuronsNeurotoxinsPeptide HydrolasesPharmacologic SubstancePhysiologicalProcessProtein DynamicsProtein EngineeringProtein IsoformsProteinsPublishingReactionReagentSerotypingStructureSystemTechniquesTetanus ToxinTimeToxinVisitbiophysical techniquescell typeclinically relevantinnovationinterestmanmembermolecular imagingnanobodiesnext generationnovelnovel strategiespreservationpreventreceptorreceptor bindingsensorsimulationsingle moleculesingle-molecule FRETstoichiometrystructural biology
项目摘要
Resolving the intoxication mechanism of botulinum neurotoxins using single molecule structural
biology.
The toxins produced by Clostridium botulinum are some of the deadliest known yet are also revered for
their pharmaceutical utility. C. botulinum is classified into seven serotypes (A-G) based on the
neurotoxins that they produce. Currently, pharmaceutical development has relied on botulinum
neurotoxin type A1 (BoNT/A). However, botulinum neurotoxin type E (BoNT/E) is currently in clinical
trials because it provides different pharmacokinetics, faster onset and shorter duration, which enable
new treatment regimes. The BoNT proteins are members of the two-component, “AB toxin” family (e.g.
tetanus, cholera, and diphtheria toxins), which inject a toxic cargo enzyme (part A) using a
proteinaceous transmembrane delivery system (part B). As such, their structure and activity has been
well studied. However, several fundamental open questions remain regarding the BoNT delivery
mechanism, such as the number of toxins required to deliver the cargo. Additionally, while numerous
structures have been solved of the dormant toxins, there is little structural information on the active
delivery state(s). AB toxins deliver their cargo across cellular membranes, typically triggered by low pH,
which causes structural changes of both parts A and B along with insertion into the membranes. The
presence of aggregation at high protein concentrations and membranes provide many experimental
challenges for techniques that rely on ensemble averaging. In contrast, single molecule fluorescence can
observe individual proteins on single liposomes to revist these classic problems in AB toxin structural
biology. These novel approaches will answer long-standing questions in the field and lead to new
understanding of the differences between two clinically relevant isoforms.
应用单分子结构技术解析肉毒神经毒素的中毒机制
生物学
肉毒梭菌产生的毒素是已知的最致命的毒素之一,但也因
他们的药物效用。C.肉毒杆菌根据血清型分为七种血清型(A-G),
它们产生的神经毒素。目前,药物开发一直依赖肉毒杆菌
A1型神经毒素(BoNT/A)。然而,肉毒杆菌神经毒素E型(BoNT/E)目前在临床上
试验,因为它提供了不同的药代动力学,更快的起效时间和更短的持续时间,
新的治疗方案。BoNT蛋白是双组分“AB毒素”家族的成员(例如,
破伤风、霍乱和白喉毒素),其使用注射器注射有毒货物酶(A部分)。
蛋白质跨膜递送系统(部分B)。因此,它们的结构和活动一直是
好好研究。然而,关于BoNT交付,仍存在一些基本的开放问题
机制,如交付货物所需的毒素数量。此外,虽然许多
虽然已经解决了休眠毒素的结构,但活性毒素的结构信息很少。
交付状态。AB毒素通过细胞膜运送它们的货物,通常由低pH触发,
这导致部分A和B沿着插入膜的结构变化。的
在高蛋白浓度和膜下聚集的存在提供了许多实验结果,
对于依赖于系综平均的技术的挑战。相反,单分子荧光可以
观察单个脂质体上的单个蛋白质,以修正AB毒素结构中的这些经典问题
生物学这些新颖的方法将回答该领域长期存在的问题,并带来新的
了解两种临床相关亚型之间的差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark E Bowen其他文献
Mark E Bowen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark E Bowen', 18)}}的其他基金
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
- 批准号:
10360516 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
- 批准号:
7735586 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
- 批准号:
7554662 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
- 批准号:
7996650 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
- 批准号:
8370963 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
- 批准号:
8986207 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
- 批准号:
8196939 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
- 批准号:
9884794 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
- 批准号:
8606894 - 财政年份:2008
- 资助金额:
$ 42.74万 - 项目类别:
相似海外基金
Development of cell based assays as replacement assays for Botulinum toxins and antitoxins
开发基于细胞的检测作为肉毒杆菌毒素和抗毒素的替代检测
- 批准号:
G1000086/2 - 财政年份:2013
- 资助金额:
$ 42.74万 - 项目类别:
Research Grant
Robust Peptide-Based Diagnostics of Botulinum Toxins
基于肽的肉毒杆菌毒素的稳健诊断
- 批准号:
8432962 - 财政年份:2012
- 资助金额:
$ 42.74万 - 项目类别:
Radioprotective Wirksamkeit intraglandulär applizierten Botulinum-Toxins (BoNT) auf die Kopfspeicheldrüsen der Wistar-Ratte nach deren Behandlung mit ionisierender Strahlung
电离辐射治疗后威斯塔大鼠唾液腺内应用肉毒杆菌毒素 (BoNT) 的辐射防护效果
- 批准号:
166669235 - 财政年份:2010
- 资助金额:
$ 42.74万 - 项目类别:
Research Grants
Development of cell based assays as replacement assays for Botulinum toxins and antitoxins
开发基于细胞的检测作为肉毒杆菌毒素和抗毒素的替代检测
- 批准号:
G1000086/1 - 财政年份:2010
- 资助金额:
$ 42.74万 - 项目类别:
Research Grant
The development of novel drug delivery systems based on the mechanism for intestinal absorption of botulinum toxins
基于肉毒杆菌毒素肠道吸收机制的新型药物递送系统的开发
- 批准号:
22500427 - 财政年份:2010
- 资助金额:
$ 42.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid detection of botulinum toxins using a high sensitivity SPR sensor
使用高灵敏度 SPR 传感器快速检测肉毒杆菌毒素
- 批准号:
7452686 - 财政年份:2009
- 资助金额:
$ 42.74万 - 项目类别:
Rapid detection of botulinum toxins using a high sensitivity SPR sensor
使用高灵敏度 SPR 传感器快速检测肉毒杆菌毒素
- 批准号:
7924013 - 财政年份:2009
- 资助金额:
$ 42.74万 - 项目类别:
Human Monoclonal Antibodies that Bind Botulinum Toxins
结合肉毒杆菌毒素的人单克隆抗体
- 批准号:
8042341 - 财政年份:2006
- 资助金额:
$ 42.74万 - 项目类别:
Human Monoclonal Antibodies that Bind Botulinum Toxins
结合肉毒杆菌毒素的人单克隆抗体
- 批准号:
8207831 - 财政年份:2006
- 资助金额:
$ 42.74万 - 项目类别:
Human Monoclonal Antibodies that Bind Botulinum Toxins
结合肉毒杆菌毒素的人单克隆抗体
- 批准号:
8432427 - 财政年份:2006
- 资助金额:
$ 42.74万 - 项目类别: